Lutetium-177 PSMA radioligand therapy shows promise in metastatic castration-resistant prostate cancer
Radioligand therapy, using targeted prostate-specific membrane antigen (PSMA) compounds, is emerging as a promising treatment…
Browsing: radioligand therapy